Leerink Partners Reiterates Outperform Rating on Repligen (RGEN)
Tweet Send to a Friend
Leerink Partners analyst Puneet Souda reiterated an Outperform rating and $200.00 price target on Repligen (NASDAQ: RGEN)The analyst comments "Bottom ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


